XML 35 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Corrections to Previously Issued Consolidated Financial Statements (Details) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Sep. 30, 2016
Sep. 30, 2015
Consolidated Statements of Balance Sheets            
Due to related party $ 953,000   $ 953,000   $ 6,500,000  
Accumulated deficit (11,848,288)   (11,848,288)   (11,323,401)  
Consolidated Statements of Operations and Comprehensive Loss            
Research and development expenses 17,500 67,848 $ 10,000,000    
Net Loss $ (127,879) $ (293,237) $ (524,887) $ (10,353,605)    
Basic and diluted loss per share $ (0.00) $ (0.00) $ (0.00) $ (0.05)    
Consolidated Statements of Cash Flow            
Net loss from operating activities $ (127,879) $ (293,237) $ (524,887) $ (10,353,605)    
Issuance of common stock for compensation $ 2,552 5,928    
(Increase) decreases in prepayment     3,815    
(Increase) decrease in due from related party          
Increase (decrease) in due to related party     (647,000) 6,477,483    
Increase (decrease) in due to shareholder     (46,586)    
Net cash used in operating activities     (1,115,484) (3,263,340)    
Proceeds from subscription receivable     350,000    
Net cash used in financing activities     $ 950,000 2,353,414    
Previously Reported [Member]            
Consolidated Statements of Balance Sheets            
Prepayment   3,500,000   3,500,000    
Due to related party      
Accumulated deficit   (669,207)   (669,207) (4,823,401)  
Consolidated Statements of Operations and Comprehensive Loss            
Research and development expenses        
Net Loss       $ (353,605) $ (4,507,799)  
Basic and diluted loss per share       $ 0  
Consolidated Statements of Cash Flow            
Net loss from operating activities       $ (353,605) $ (4,507,799)  
Issuance of common stock for compensation          
(Increase) decreases in prepayment       (3,496,185)    
(Increase) decrease in due from related party       350,000    
Increase (decrease) in due to related party       (22,517) (22,517)  
Increase (decrease) in due to shareholder       (46,586)    
Net cash used in operating activities       (3,857,447)   $ (517)
(Increase) decrease in due to shareholder          
Proceeds from subscription receivable          
Proceeds from issuance of common stock       897,521    
Net cash used in financing activities       2,947,521    
Adjustments [Member]            
Consolidated Statements of Balance Sheets            
Prepayment   (3,500,000)   (3,500,000)    
Due to related party   6,500,000   6,500,000 6,500,000  
Accumulated deficit   (10,000,000)   (10,000,000) (6,500,000)  
Consolidated Statements of Operations and Comprehensive Loss            
Research and development expenses       10,000,000 10,000,000  
Net Loss       $ (10,000,000) $ (6,499,940)  
Basic and diluted loss per share       $ (0.05) $ (0.06)  
Consolidated Statements of Cash Flow            
Net loss from operating activities       $ (10,000,000) $ (6,499,940)  
Issuance of common stock for compensation       897,521    
(Increase) decreases in prepayment       3,500,000    
(Increase) decrease in due from related party       (350,000)    
Increase (decrease) in due to related party       6,500,000 6,500,000  
Increase (decrease) in due to shareholder       46,586    
Net cash used in operating activities       594,107  
(Increase) decrease in due to shareholder       46,586    
Proceeds from subscription receivable       350,000    
Proceeds from issuance of common stock       (897,521)    
Net cash used in financing activities       (594,107)    
Restated [Member]            
Consolidated Statements of Balance Sheets            
Prepayment        
Due to related party   6,500,000   6,500,000 6,500,000  
Accumulated deficit   $ (10,669,207)   (10,669,207) (11,323,401)  
Consolidated Statements of Operations and Comprehensive Loss            
Research and development expenses       10,000,000 10,000,000  
Net Loss       $ (10,353,605) $ (11,007,799)  
Basic and diluted loss per share       $ (0.05) $ (0.06)  
Consolidated Statements of Cash Flow            
Net loss from operating activities       $ (10,353,605) $ (11,007,799)  
Issuance of common stock for compensation       897,521    
(Increase) decreases in prepayment       3,815    
(Increase) decrease in due from related party          
Increase (decrease) in due to related party       6,477,483 $ 6,477,483  
Increase (decrease) in due to shareholder          
Net cash used in operating activities       (3,263,340)   $ (715)
(Increase) decrease in due to shareholder       (46,586)    
Proceeds from subscription receivable       350,000    
Proceeds from issuance of common stock          
Net cash used in financing activities       $ (2,353,414)